Clinical Trials Browser

Phase 2 × Pancreatic Cancer Resectable × Gemcitabine × Clear all

NCT03344172 2020-05-14

17-134

Phase 2 Terminated

32 enrolled 14 charts

Gastrointestinal

Pancreatic Cancer Resectable